2016 International Congress Archives - Page 149 of 207

A 12-month, 2-arm, 2-period, randomized, controlled trial of a digital solution for the management of Parkinson’s disease (PD): Rationale and study design

S. Papapetropoulos, G. Mitsi (Boston, MA, USA)
A case of hemifacial spasm with a right-sided pontine meningioma that resolved with PICA loop vascular decompression surgery

E.M. Feinstein, S.J. Frucht (New York, NY, USA)
A case of misdiagnosed Parkinson’s disease (PD)

I. Gabrielyan, K. Harutyunyan, G. Avagyan, H. Amirjanyan, A. Voskanyan, S. Khachaturyan, H. Hambardzumyan, A. Nazaryan, H. Manvelyan (Yerevan, Armenia)
A case of PD with non -motor symptoms onset

L. Khachatryan, N. Gasparyan, E. Mamyan, N. Mamyan, A. Hakobyan (Yerevan, Armenia)
A case of thalamic malignant glioma formation in a patient with STN-DBS for Parkinson’s disease

A. Tomskiy, A. Gamaleya, N. Gubareva, Y. Latyshev, G. Kobyakov, L. Shishkina, I. Pronin (Moscow, Russia)
A case series of sigmoid volvulus in Parkinson’s disease

K. Khalid, A. McColl, M. Gosney, A.K. Chatterjee (Reading, United Kingdom)
A case with posttraumatic functional shoulder dyskinesia

S. Tezcan, M. Demirci, M.C. Akbostanci (Ankara, Turkey)
A clinical trials ‘charter’ to improve communication about, recruitment to and retention in Parkinson’s clinical trials

C. Carroll, I. Tom, M. Helen, S. Jon (Plymouth, United Kingdom)
A clinico-genetical study in a large cohort of patients with spastic paraplegia type 4 (SPG4)

A. Orlacchio, M. Mearini, L. Pedace, A. Casella, C. Montecchiani, F. Gaudiello, M. Maurialuisa, R. Massa, C. Caltagirone, R.P. Munhoz, J.L. Pedroso, O.G.P. Barsottini, T. Kawarai (Rome, Italy)
A cognitive fMRI study of non-manifesting LRRK2 and GBA carriers

A. Thaler, N. Bregman, A. Mirelman, T. Gurevich, M. Gana-Weiss, A. Orr-Urtreger, T. Hendler, N. Giladi (Tel-Aviv, Israel)
A cognitive monitoring program for individuals with Parkinson’s disease submitted to deep brain stimulation

L. Fontão, R. Barreto, L. Ruano, A. Sousa, A.I. Martins, A. Costa, A. Aires, C. Sousa, J. Lima, J. Pais, M.J. Rosas, R. Vaz, V.T. Cruz (Santa Maria da Feira, Portugal)
A combined therapeutic approach in the management of abnormal postures in Parkinson’s disease

S. Di Martino, E. Unti, C. Tramonti, S. Mazzucchi, U. Bonuccelli, B. Rossi, R. Ceravolo, C. Chisari (Pisa, Italy)
A community organizing approach to identify and address the barriers to healthcare for XDP patients in Panay Island, Philippines

G.M. Solinap, A.C. Aguil, P.B. Acuna, L.V. Lee, N. Sharma (Charlestown, MA, USA)
A comparative study of clinical profile of patients of drug induced parkinsonism with idiopathic Parkinson’s disease

S. Kushwaha, R. Mistry, A. Anthony, S. Khurana (Delhi, India)
A comparison of deep brain stimulation and continuous intrajejunal levodopa infusion in advanced Parkinson’s disease: The INVEST study

D. van Poppelen, R.M.A. de Bie, J.M. Dijk (Amsterdam, Netherlands)
A comparison of self-report and performance-based balance measures to predict recurrent falls in people with Parkinson’s disease: A cohort study

L.R.S. Almeida, G.T. Valenca, N.N. Negreiros, E.B. Pinto, J. Oliveira-Filho (Salvador, Brazil)
A comparison of standards of care in Parkinson’s disease between a general neurology clinic and a specialist movement disorders clinic based on the UK NICE guidelines

S.M. Yap, M.O. Dablouk, S. O'Sullivan (Dublin, Ireland)
A comparison study of health-related quality of life between female and male patients with Parkinson’s disease

B. Donmez Colakoglu, T. Kahraman, E. Goz, F. Soke, A. Genc, P. Keskinoglu (Izmir, Turkey)
A comprehensive characterisation of the salivary proteome of patients with Parkinson’s disease

J.M. Masters, A.J. Noyce, S. Lynham, T.T. Warner, G. Giovannoni, G.B. Proctor (Herts, United Kingdom)
A computational model of iron transport between the blood circulation and the brain

V. Tjendana-Tjhin, S. Mitchell, E.A. Milward, M.J. Chappell, J.F. Collingwood (Coventry, United Kingdom)
A computerized cognitive behavioral therapy randomized, controlled, pilot trial for insomnia in Parkinson’s disease (The ACCORD-PD study)

S. Patel, O. Ojo, G. Genc, L. Wang, J. Benab, M. Drerup, N. Foldvary, A. Ahmed, H.H. Fernandez (Cleveland, OH, USA)
A cross-linguistic approach to speech intelligibility in people with PD

Y. Kim, Y. Choi (Baton Rouge, LA, USA)
A cross-sectional study in spinocerebellar ataxia type 12 (SCA-12) patients from a tertiary care center in Eastern India

S. Chatterjee, R. Banerjee, B. Mondal, M.U. Kulsum, K. Chatterjee, S.S. Jha, P. Chatterjee, S. Choudhury, S.S. Anand, H. Kumar (Kolkata, India)
A cross-sectional study of sensor-based gait analysis in atypical Parkinsonian disorders

C. Raccagni, H. Gassner, S. Eschlböck, S. Bösch, F. Krismer, M. Nocker, K. Seppi, W. Poewe, J. Klucken, G. Wenning (Innsbruck, Austria)
A crossover study of pretarsal and preseptal injections of botulinum toxin type A (BTX-A) in the treatment of hemifacial spasm and blepharospasm

A. Choolam, K. Kulkantrakorn, P. Lolekha (Pathumthani, Thailand)
A descriptive study on the safety and feasibility of mesenchymal stem cell therapy for Parkinson’s disease: A case series

M.J.O.V. Buensalido, J.J.A. Tiongson (Pasig City, Philippines)
A dopamine-dependent activity of the STN in the control of balance in Parkinson’s disease

G. Arnulfo, N.G. Pozzi, C. Palmisano, A. Canessa, J. Brumberg, C.A. Frigo, G. Pezzoli, F. Steigerwald, J. Volkmann, I.U. Isaias (Würzburg, Germany)
A double blind investigation of efficacy and safety of incobotulinumtoxinA in Parkinson’s disease tremor- A customized injection approach

S.O. Mittal, R. Rostami, D.G. Machado, D. Richardson, B. Jabbari (Cleveland, OH, USA)
A double-blind randomized controlled trial of cognitive training for freezing of gait in Parkinson’s disease

C.C. Walton, L. Mowszowski, J.M. Shine, M. Gilat, J.M. Hall, C. O'Callaghan, A.J. Muller, M. Georiades, J.Y.Y. Szeto, K.A. Ehgoetz Martens, S.L. Naismith, S.J.G. Lewis (Sydney, Australia)
A dynamic causal model of the superior colliculus: Inhibitory activity increases with the temporal discrimination threshold

B. Quinlivan, R. Moran, E. McGovern, S. Narasimham, I. Beiser, L. Williams, O. Killian, R. Beck, S. O'Riordan, J.S. Butler, M. Hutchinson, R.B. Reilly (Dublin, Ireland)
A functional magnetic imaging study of the response in the superior colliculus to looming stimuli in cervical dystonia patients and their relatives

E.M. Mc Govern, S. Narasimham, O. Killian, I. Beiser, L. Williams, B. Quinlivan, J.S. Butler, S. O'Riordan, R.B. Reilly, M. Hutchinson (Dublin, Ireland)
A health cost analysis for Huntington disease in Peru

G. Silva-Paredes, M. Cornejo-Olivas, M. Inca-Martinez, K. Espinoza-Huertas, A. Vishnevetsky, P. Mazzetti, R. Urbanos-Garrido (Lima, Peru)
A healthy volunteer phase 1 study of RE-024, a potential phosphopantothenate replacement therapy for patients with pantothenate kinase-associated neurodegeneration (PKAN)

R.D. Marshall, A. Harring-Abbott, K. Lucey, K. Leach, M. Beconi, J. Hunt, H. Plotkin (San Diego, CA, USA)
A heterozygous splicing mutation c.823-10G>T at the intron9/exon 10 of the MAPT gene in an Irish family with FTDP- 17

E.M. Fallon, D.A. Olszewska, C. McGuigan, I. Delon, F. Brett, B. Lawlor, M. Hutchinson, M. Hutton, T. Lynch (Dublin, Ireland)
A heterozygous splicing variant in NPC2 in a patient with PSP

C. Castro-Fernández, C. García-Sancho, V. Rodríguez-Sureda, R. Martínez-Regueiro, P. Aguiar, P. Blanco-Arias, C. Pérez-Sousa, P. Díaz, C. Domínguez, M. Fernández-Prieto, T. García-Sobrino, J. Cortés, M. Arias, M.J. Sobrido (Santiago de Compostela, Spain)
A homozygous loss-of-function mutation in DNAJA3 causes hereditary motor and sensory neuropathy with spastic paraplegia (HMSN type V)

T. Kawarai, R. Miyamoto, Y. Kuroda, M. Omoto, M. Ueyama, N. Murakami, T. Furukawa, R. Oki, A. Mori, Y. Osaki, C. Banzrai, H. Nodera, A. Orlacchio, A. Hashiguchi, Y. Higuchi, H. Takashima, T. Kanda, Y. Izumi, Y. Nagai, T. Mitsui, R. Kaji (Tokushima, Japan)
A largest case series study of spinocerebellar ataxia type 2(SCA2) from India: Do SCA2 clinical subtypes exists?

A.K. Srivastava, A.K. Sonakar, S. Shakya, V. Suroliya, A. Takkar, I. Ahmad, R.K. Singh, I. Singh, D. Vibha, G. Shukla, V. Goyal, K. Prasad, A. Garg, M. Faruq (New Delhi, India)
A longitudinal observational study of a cohort of patients with PSP/CBD: The JALPAC project

T. Tokuda, T. Ikeuchi, H. Takigawa, I. Aiba, T. Shimohata, M. Morita, O. Onodera, S. Murayama, K. Nakashima (Kyoto, Japan)
A longitudinal study of functional deterioration of primary olfactory cortex in early-stage Parkinson’s disease

J. Wang, Z. Mosher, T. Subramanian, Q.X. Yang (Hershey, PA, USA)
A multi-centre European comparative survey of advanced therapies (infusion and deep brain stimulation) in Parkinson’s disease

A.M. Rizos, P. Martinez-Martin, P. Reddy, M. Silverdale, K. Ashkan, A. Antonini, D. Calandrella, P. Odin, T. Henriksen, N. Bryndum, A. Glad, M.G. Kramberger, Z. Pirtošek, M. Trošt, T. van Laar, R. Katzenschlager, H.S. Dafsari, L. Timmermann, A. Storch, H. Reichmann, K. Ray Chaudhuri, On behalf of EUROPAR, The IPMDS Non-Motor PD Study Group (London, United Kingdom)
A multi-site survey of Parkinson’s disease deep brain stimulation center best practice: moving toward a standard of care for DBS

A.A. Butala, K.A. Mills, P. Schmidt, M.S. Okun, Z. Mari (Baltimore, MD, USA)
A national case study of virtual care visits for Parkinson’s disease (RACE-PD): Interim assessment of participant and investigator experiences

R. Korn, H.T. Keenan, T. Felong, S. Goldenthal, S. Kanchana, H. Schwarz, S. Sharma, K. Andrzejewski, E.A. Stevenson, R. Barbano, G. Kang, K. Rizer, A. Shukla, M.J. Dodge, C. Tanner, M. Katz, R. Rodriguez, N. Galifianakis, W. Zhu (Rochester, NY, USA)
A new test for the measuring hand functions in Parkinson’s disease: Psychometric evaluation of the squares test

E. Goz, F. Soke, A. Genc, B. Donmez Colakoglu, P. Keskinoglu (Izmir, Turkey)
A new tool to measure the impact of deep brain stimulation on Parkinson’s disease patients: Development and validation of the deep brain stimulation impairment scale (DBS-IS)

F. Maier, C.J. Lewis, A.A. Kühn, H. Krug, J. Volkmann, A.D. Kirsch, L. Wojtecki, A. Schnitzler, G. Deuschl, J.K. Krauss, C. Woopen, L. Timmermann (Cologne, Germany)
A new tool to stage Parkinson’s disease PDCS (Parkinson’s disease composite scale): A pilot study on behalf of the European Parkinson’s disease association (EPDA)

F. Stocchi, P. Martinez-Martin, F.G. Radicati (Rome, Italy)
A novel C. elegans model for identification of small molecules that target alpha-synuclein-mediated toxicity

L.V. Kalia, K. Menezes, Y. Zhang, S. Ishikura, N. Tran, H. Chau, A.M. Lozano, S.K. Kalia, J.G. Culotti, S. Suo, W.S. Ryu (Toronto, ON, Canada)
A novel causal mutation for spinocerebellar ataxia 19/22 (SCA19)

C.M. Testa, V. Norris, J. Hoder, V. Hagood, R. Lewandowski, G.N. Tseng (Richmond, VA, USA)
A novel haplotype in LRRK2 is associated with risk for multiple system atrophy in the Korean population

L.L. Farrell, E. Scott, H.J. Kim, I. Guella, S. Bortnick, E.M. Nosova, B. Jeon, C.W. Sin, H. Park, S.S. Park, M.J. Farrer (Vancouver, Cameroon)
A novel homozygous DJ1 mutation causes parkinsonism and ALS in a Turkish family

H.A. Hanagasi, A. Giri, G. Guven, B. Bilgic, A.K. Hauser, M. Emre, P. Heutink, N. Basak, T. Gasser, J. Simón-Sánchez, E. Lohmann (Istanbul, Turkey)
A novel interdisciplinary palliative care clinic for advanced Parkinson’s disease and Parkinsonian syndromes

K.K. Tuck, L. Mann, S. Anderson, T. Borcich, J. Wilhelm, L. Bryans, J. Carter (Portland, OR, USA)
A novel phenotype associated with GRN mutations: Spastic ataxia

I. Faber, J.R.M. Prota, A.R.M. Martinez, B.S. Carvalho, Í.T. Lopes-Cendes, M.C. França Jr (Campinas, Brazil)
A novel phenotype of amyloid precursor protein (APP) mutation presenting with dementia, and symptoms of both progressive supranulcear palsy (PSP) and multisystem atrophy (MSA)

J.E. Staisch, M. Padmanaban, J. Mastrianni, T. Xie (Chicago, IL, USA)
A novel single molecule imaging approach to detect individual protein oligomers in CSF from patients with Parkinson’s disease (PD)

S. Gandhi, M.H. Horrocks, S.F. Lee, N.W. Wood, D. Klenerman (London, United Kingdom)
A peripheral pathway to restless legs syndrome? Clues from familial amyloid polyneuropathy

T. Teodoro, P. Viana, D. Abreu, I. Conceição, R. Peralta, J.J. Ferreira (Lisboa, Portugal)
A phase 3, placebo-controlled study with an open-label extension: Sustained incobotulinumtoxinA efficacy in upper-limb post-stroke spasticity over 48 weeks

P. Kanovský, A. Brashear, E.P. Elovic, M.C. Munin, A. Hanschmann, R. Hiersemenzel, C. Marciniak (Olomouc, Czech Republic)
A phase II, pragmatic, randomized clinical trial on a high-intensity exercise and fall prevention boot camp for Parkinson’s disease: Feasibility and safety

M.R. Landers, J.W. Navalta (Las Vegas, NV, USA)
A phase II, pragmatic, randomized clinical trial on a high-intensity exercise and fall prevention boot camp for Parkinson’s disease: Signal of efficacy

M.R. Landers, J.W. Navalta (Las Vegas, NV, USA)
A pilot study of horizontal current steering with chronically implanted segmented electrodes for STN-DBS in Parkinson’s disease

F. Steigerwald, L. Mueller, S. Johannes, C. Matthies, J. Volkmann (Würzburg, Germany)
A pilot study of SD-809 (deutetrabenazine) in tics associated with Tourette syndrome

J. Jankovic, J. Jimenez-Shahed, C. Budman, B. Coffey, T.K. Murphy, D. Shprecher, D. Stamler (Houston, TX, USA)
A pilot study of whole exome sequencing in progressive supranuclear palsy

K.Y. Mok, A. Tucci, R. de Silva, H.R. Morris, A.B. Singleton, H. Houlden, J. Hardy, IPDGC (London, United Kingdom)
A polysomnography study of REM sleep without atonia and REM sleep behavior disorder in MSA and PD

C. Kaindlstorfer, G. Wenning, S. Bösch, B. Frauscher, F. Krismer, M. Nocker, G. Ransmayr, C. Scherfler, K. Seppi, A. Stefani, W. Poewe, B. Högl (Innsbruck, Austria)
A proposed Parkinson’s disease neuropsychological battery (PNB)

L.L. van Wanrooij, J. Hoogland, J.G. Goldman, G. Stebbins, G.J. Geurtsen, D. Weintraub (Amsterdam, Netherlands)
A prospective study of patients’ expectations in subthalamic nucleus deep brain stimulation for Parkinson’s disease

N.R. Mundil, H.Y. Ling, H. Hasegawa, M. Samuel, K. Ashkan (London, United Kingdom)
A randomized clinical trial of atomoxetine treatment for mild cognitive impairment (MCI) in Parkinson’s disease (PD)

V.K. Hinson, J. Elm, A. Delambo, T. Turner (Charleston, SC, USA)
A randomized controlled clinical study to evaluate efficacy, safety and tolerability of SC L-dopa/carbidopa (ND0612H) infusion regimens in fluctuating PD patients

K. Kieburtz, C.W. Olanow, Y. Cohen, S. Oren (Rochester, NY, USA)
A randomized double-blind placebo- and positive-controlled crossover study to evaluate the effects of single doses of SD-809 (deutetrabenazine) and tetrabenazine on the corrected QT interval

D. Stamler, E. Offman, M. Bradbury, L. De Boer (La Jolla, CA, USA)
A randomized, double-blind, placebo-controlled trial of deutetrabenazine for the treatment of tardive dyskinesia (ARM-TD)

H.H. Fernandez, S.A. Factor, R.A. Hauser, J. Jimenez-Shahed, W. Ondo, M.S. LeDoux, D. Shprecher, T. Simuni, D. Stamler, K.E. Anderson (Cleveland, OH, USA)
A rapid chemical-genetic screen utilising impaired movement phenotypes in caenorhabditis elegans

K. Schmeisser, Y.F. Ghassemi, C. Maios, A. Parker (Montreal, QC, Canada)
A rare genetic transcriptomopathy syndrome involving TAF1 leading to insights into more common neurologic disorders, including X-linked dystonia-parkinsonism (XDP)

G.J. Lyon (New York, NY, USA)
A step forward to the future: UPDRS kinematic measures for telemedicine

G. Albani, C. Azzaro, F. Parisi, C. Ferraris, M. Giuberti, L. Contin, D. Pianu, L. Pradotto, V. Cimolin, N. Cau, M. Galli, R. Nerino, G. Ferrari, A. Mauro (Piancavallo, Italy)
A strategy to classify Parkinson’s disease patients with dyskinesia: The analysis of center of pressure with impact of cognitive loading

W. Buated, P. Lolekha, T. Fujinami, S. Hidaka (Nomi, Japan)
A study to assess the quality of life and strain in caregivers of people with Parkinson’s disease in India

F. Pullishery, F. Fawaz (Malappuram, India)
A survey of impulse control disorders in Chinese patients with Parkinson’s disease and literature review

Q. Xiao, X. Wang, Y. Tan, M. Wei (Shanghai, People's Republic of China)
A survey of movement disorders in a large sample of patients treated with antipsychotic medication

B. Balint, H. Killaspy, T.R.E. Barnes, N. Freemantle, E. Joyce, D. Martino, K.P. Bhatia (London, United Kingdom)
A technological solution for monitoring Parkinson’s disease: A patient-based perspective on necessity, usability and acceptability

S. Couth, E. Poliakoff, J. Vega, C. Jay, S. Harper, R. Almutiry, T.F. Cootes, A.M. Ramsay, S.A. Kotz (Manchester, United Kingdom)
A unique phenotype associated with anti-GAD antibodies

A.P. Mentreddi, S. Chitnis, P. Khemani (Dallas, TX, USA)
A validation study of a smartphone-based finger tapping application for quantitative assessment of bradykinesia in Parkinson’s disease

C.Y. Lee, S.J. Kang, Y.E. Kim, U. Lee, H.I. Ma, Y.J. Kim (Anyang-si, Gyeonggi-do, Korea)
A web resource on levodopa-induced dyskinesia (LID) genetics

M. Falla, H. Blankenburg, P. Gruber, I. Pichler, C. Schwienbacher, A. Hicks, F. Domingues, P.P. Pramstaller (Bolzano/Bozen, Italy)
A whole brain anatomical network model and its application in PD research

X. Lei, T. Chen, X. Hu, B. Zhang (Kunming, People's Republic of China)
Abnormal findings in polisomnographic records of patients with spinocerebellar ataxia type 2 (SCA2)

A. Zanatta, A.C.d.S. Crippa, F.M.B. Germiniani, H.A.G. Teive (Curitiba, Brazil)
Abnormal intrinsic brain activity reveals neural correlates of impaired cognitive function in early stage of Huntington’s disease (HD): A resting-state fMRI study

W. Liu, J. Yang, K. Chen, C. Luo, J.M. Burgunder, Q. Gong, H. Shang (Chengdu, People's Republic of China)
Abnormal motor sequence representation in dystonia

M.J. Jaynes, J.W. Mink (Rochester, NY, USA)
AbobotulinumtoxinA for cervical dystonia: A meta-analysis of injection practices across 5 countries

R. Trosch, V.P. Misra, P. Maisonobe, S. Om (Farmington Hills, MI, USA)
AbobotulinumtoxinA for cervical dystonia: International treatment patterns

T.M. Chung, C. Colosimo, V.P. Misra, D. Charles, P. Maisonobe, S. Om (São Paulo, Brazil)
Accuracy of clinical diagnosis of dementia with Lewy bodies: A systematic review and meta-analysis

G. Rizzo, S. Arcuti, M. Copetti, M. Alessandria, R. Savica, A. Fontana, R. Liguori, G. Logroscino (Bologna, Italy)
Accuracy of intraoperative CT during DBS procedures: Comparison with postoperative MRI

L. Verhagen Metman, P. van den Munckhof, R. Bakay, G. Stebbins, M. Bot (Chicago, IL, USA)
Active movement discrimination of the ankle in Parkinson’s disease

H.E. Teasdale, E.A. Preston, G. Waddington (Canberra, Australia)
Activities of daily living and motor scores of the UPDRS in fluctuating Parkinson’s disease patients treated with opicapone

J. Ferreira, A. Lees, O. Rascol, T. Müller, A. Santos, I. Oliveira, N. Lopes, J.F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)
Acute admissions in people with Parkinson’s – More than just frailty

N. Leopold, B. Mohamed, C. Thomas (Cardiff, United Kingdom)
Acute cerebellar degeneration as the first manifestation of Sjögren syndrome: A case report

R. Maciel, S. Camargos, F. Cardoso (Belo Horizonte, Brazil)
Acute movement disorders in Tunisian childhood

H. Benrhouma, H. Klaa, A. Nasri, I. Kraoua, I. Turki (Tunis, Tunisia)
ADCY5 screening in paediatric-onset hyperkinetic movement disorders: Report of three new Italian families

M. Carecchio, N.E. Mencacci, G. Zorzi, F. Zibordi, C. Fusco, A. Iodice, L. Veneziano, C. Barzaghi, L. 'RBibo, N. Wood, B. Garavaglia, N. Nardocci (Milan, Italy)
Adenosine A2A receptor antagonist istradefylline might have efficacy to fatigue and depression in some patients of Parkinson’s disease

H. Ito, T. Kamei (Fujisawa, Japan)
ADS-5102 (amantadine HCl) extended-release capsules reduced levodopa-induced dyskinesia in the phase 3 EASE LID study

R. Pahwa, C.M. Tanner, R.A. Hauser, P. Nausieda, D.D. Truong, K. Hull, P. Agarwal, R. Johnson, A.E. Ruby, N.L. McClure, M.J. Stempien (Kansas City, KS, USA)
Adult onset Niemann-Pick type C: 24 month follow-up on miglustat

B. Elibol, F. Ozkinay, H. Onder (Ankara, Turkey)
Affective theory of mind in Parkinson’s disease

A.M. Hammad, S. Ghozy, S.I. El-Jaafary (Cairo, Egypt)
Age associated effects of levodopa administration on striatal acetylcholinesterase activity

M. Messripour, A. Mesripour (Isfahan, Islamic Republic of Iran)
Airway protective mechanisms and deep brain stimulation in Parkinson’s disease

M.S. Troche, A.E. Brandimore, K.W. Hegland, P.W. Davenport, K.F. Foote, M.S. Okun (New York, NY, USA)
Alcohol-responsive action myoclonus of the leg in prostate cancer: A novel paraneoplastic syndrome

P. Termsarasab, S.J. Frucht (New York, NY, USA)
Allele specificity in neurodegenerative olfactory dysfunction

B.A. Chase, K. Markopoulou, P. Robowski, A. Strongosky, E. Narozanska, E.J. Sitek, M. Berdynski, M. Barcikowska, M.C. Baker, R. Radamakers, J. Slawek, Z.K. Wszolek (Omaha, NE, USA)
Alpha synuclein and crystallin expression in human lens in Parkinson’s disease

S.A. Schneider, E. Richert, G. Kuhlenbäumer, B. Nölle, K.P. Bhatia, G. Deuschl, J. Roider, A. Klettner (München, Germany)
Alpha-synuclein – super-resolution microscopy reveals potential new role of alpha-synuclein at the pre-synapse

J. Lautenschlaeger, F. Stroehl, A. Stephens, C.F. Kaminski, G.S. Kaminski Schierle (Cambridge, United Kingdom)
Alpha-synuclein aggregates of cardiac sympathetic nerves in synucleinopathies and in neurologically unimpaired subjects. Correlation with sympathetic denervation

M. Carmona-Abellán, I. Marcilla, I. Martínez-Valbuena, T. Tuñón, R. Luquin-Piudo (Pamplona, Spain)
Alpha-synuclein gene variants may predict neurostimulation outcome

D. Weiss, S. Herrmann, L. Wang, C. Schulte, K. Brockmann, C. Plewnia, T. Gasser, M. Sharma, A. Gharabaghi, R. Krüger (Tübingen, Germany)
Alpha-synuclein in gastric and colonic mucosa in Parkinson’s disease: Limited role as a biomarker

S.J. Chung, J. Kim, H.J. Lee, H.S. Ryu, K.W. Jung, M.J. Kim, M.J. Kim, S.M. Hong, S.J. Myung (Seoul, Korea)
Alpha-synuclein levels and dimerization in erythrocytes of Parkinson’s disease patients

N. Papagiannakis, C. Koros, M. Stamelou, A.M. Simitsi, M. Maniati, R. Antonelou, D. Papadimitriou, G. Dermentzaki, M. Moraitou, H. Michelakakis, L. Stefanis (Chaidari, Greece)
Alterations in 14-3-3 protein phosphorylation as a biomarker for neurodegeneration

T. Yacoubian, X. Chi, G. Cutter, M. McFerrin (Birmingham, AL, USA)
Alterations in muscle synergies in early stage Parkinson’s disease

J.F. Daneault, G. Vergara-Diaz, C. Adans-Dester, G. Ferreira-Carvalho, V.C.K. Cheung, P. Bonato (Charlestown, MA, USA)
Altered brain activation in complex walking conditions in patients with Parkinson’s disease

I. Maidan, K. Rosenberg-Katz, Y. Jacob, N. Giladi, J.E. Deutsch, A. Mirelman, J.M. Hausdorff (Tel Aviv, Israel)
Altered cerebello-thalamo-cortical pathway in Huntington’s disease

J.F. Martín-Rodríguez, M. Gómez-Crespo, M.T. Cáceres-Redondo, L. Vargas-González, F.J. Palomar, P. Porcacchia, P. Álvarez de Toledo, J.M. Oropesa-Ruiz, F. Carrillo, I. Huertas-Fernández, S. Jesús, P. Mir (Seville, Spain)
Altered connectivity within the cerebello-thalamo-cortical network in essential tremor: A resting state fMRI study

V. Nicoletti, I. Pesaresi, S. Fabbri, S. Giannoni, U. Bonuccelli, M. Cosottini, R. Ceravolo (Pisa, Italy)
Altered glutamate response and calcium dynamics in iPSC derived striatal neurons from XDP-patients

P. Capetian, N. Stanslowsky, E.M. Bernhardi, M. Naujock, K. Grütz, A. Domingo, P. Seibler, F. Wegner, C. Klein (Lübeck, Germany)
Altered inter-hemispheric functional coordination in primary blepharospasm

J. Yang, C. Luo, W. Song, Q. Wei, R. Ou, Y. Hou, Q. Gong, H. Shang (Chengdu, People's Republic of China)
Altered resting-state functional interhemispheric connectivity in Parkinson’s disease

X. Dan, S. Lin, A. Liu, Z. Wang, M.J. McKeown, P. Chan (Beijing, People's Republic of China)
Alternating hemiplegia of childhood (AHC) as a new presentation of adenylate cyclase 5 (ADCY5)-mutation-associated disease

C. Max, A. Westenberger, N. Brueggemann, A. Domingo, K. Gruetz, H. Pawlack, A. Weissbach, A.A. Kuehn, J. Spiegler, A.E. Lang, J. Sperner, V.S.C. Fung, J. Schallner, G. Gillessen-Kaesbach, A. Muenchau, C. Klein (Lübeck, Germany)
Alternating hemiplegia of childhood: Movement disorders and epilepsy due to mutuations in ATP1A3

A.P. Kleinert-Altamirano, M.O. Fiesco-Roa, K. Brockmann, E. Liebermann-Hernández, C. Marques-Lourenco (Tuxtla Gutiérrez, Mexico)
Alternatives for reducing chorea in Huntington disease, a long-term trial (ARC-HD): Updated week 8 results for the switch cohort

V. Sung, D. Stamler, D.O. Claassen (Birmingham, AL, USA)
Ambulatory assessment of tremor

M. Horne, S. O'Connor, P. Churchward, T. Perera, M. Braybrook (Parkville, Australia)
Amelioration of αLPHA-synuclein aggregation and motor behavior deficits by apocyanin in intranigral lipopolysaccharide induced animal model of Parkinson’s disease

B. Nehru, N. Sharma (Chandigarh, India)
AMP kinase regulates ligand-gated K-ATP channels in substantia nigra dopamine neurons

S.W. Johnson, Y. Wu, A.C. Munhall, K.Z. Shen (Portland, OR, USA)
An atypical case of adult-onset, levodopa-responsive, paroxysmal dystonia

V.N. Holiday (Portland, OR, USA)
An elderly patient presenting as pure akinesia with gait freezing (PAGF): Idiopathic aqueductal stenosis-associated hydrocephalus

K.Y. Kwon, J.J. Joo, B.J. Ahn, D.K. Yeo (Gumi, Kyeongsangbuk-do, Korea)
An exuberant cortical γb influences the unmasking and intensity of dyskinesia in 6-OHDA-treated freely-moving rats

S. Galati, V. D'Angelo, A. Salvadè, A. Kaelin, A. Stefani (Lugano, Switzerland)
An innovative international educational network to improve physicians’ current management practices of patients with cervical dystonia and spasticity

C. Colosimo, K. Bhatia, R. Bhidayasiri, T.M. Chung, L.J. Jacinto, T. Landreau, K. Fheodoroff (Terni, Italy)
An international, randomized, sham controlled trial of focused ultrasound thalamotomy for essential tremor

W. Ondo, J. Elias, N. Alicacem, P. Ghanouni (Houston, TX, USA)
An investigation of Parkinson’s disease patients’ desired control over the DBS stimulator

C.S. Kubu, J. Vitek, S.E. Cooper, A. Machado, P.J. Ford (Cleveland, OH, USA)
An ongoing phase 2, multi-centre, open-label, study of WTX101 in Wilson disease patients – Early observations

A. Czlonkowska, K.H. Weiss, A. Ala, F. Askari, D. Nicholl, M.L. Schilsky (Warsaw, Poland)
An open label trial to test the modulation of cerebellar motor pathways in primary orthostatic tremor using rTMS and fMRI

C. Gallea, E. Roze, S. Lehéricy, M. Vidailhet, S. Meunier (Paris, France)
An optimized formulation of velocity distribution in digital spiral analysis to differentiate essential tremor and Parkinson’s disease

K.H. Chen, Y.J. Chen, P.C.L. Lin, B.S. Yang, C.H. Lin, R.M. Wu (Hsin-Chu, Taiwan)
An update on genotype-phenotype correlation in X-linked dystonia-parkinsonism (XDP/DYT3)

M.E. Dy, C.M. De Gusmao, M.E. Talkowski, T.J. Multhaupt-Buell, L.R. Paul, C. Bragg, N. Sharma (Boston, MA, USA)
Analysis of cognitive disorders of Parkinson’s disease (PD) in the comparative aspect

S. Lukmonov, D. Tolibov, A. Sobirov, F. Yunusov, D. Jalilov, K. Abdukhalimova, A. Kalendarev (Tashkent, Uzbekistan)
Analysis of factors associated with cognitive and functional performance in Parkinsonian with normal mini-mental state examination

R. Breder, M.A.A. Leite, M.C.A. Ribas, M. Orsini (Niterói, Brazil)
Analysis of LINGO1 and LINGO2 genes in essential tremor and Parkinson’s disease

N.Y. Abramycheva, M.S. Stepanova, E.Y. Fedotova, E.O. Ivanova, S.N. Illarioshkin (Moscow, Russia)
Analysis of MAPT, GRN and C9orf72 genes in progressive supranuclear palsy, corticobasal syndrome and frontotemporal lobar degeneration in Russian population

E.Y. Fedotova, N.Y. Abramycheva, M.S. Stepanova, A.S. Vetchinova, S.N. Illarioshkin (Moscow, Russia)
Analysis of relationships between spinal deformity and walking ability in Parkinson’s disease patients

Y. Nakamura, Y. Machida, T. Hanawa, M. Kanai, K. Tajima, S. Asano (Satte, Japan)
Analysis of temporal gait features extracted from accelerometer-based signals during ambulatory walking in Parkinson’s disease

M. Boutaayamou, M. Demonceau, O. Brüls, J.G. Verly, G. Garraux (Liège, Belgium)
Analysis of the genetic variability in Parkinson’s disease from southern Spain

S. Bandres-Ciga, N.E. Mencacci, R. Durán, F.J. Barrero Hernández, F. Escamilla-Sevilla, S. Morgan, J. Hehir, F. Vives, J. Hardy, A.M. Pittman (Granada, Spain)
Analysis of the olfactory impairments in PINK1 deficient mice

A. Hummel, A. Zimprich, L. Garret, B. Sperling, F. Giesert, J. Nagler, H. Fuchs, V. Gailus-Durner, M. Hrabé de Angelis, S.M. Koch, D. Vogt Weisenhorn, W. Wurst (Neuherberg, Germany)
Anhedonia and its correlation with clinical aspects in Parkinson’s disease

H. Nagayama (Tokyo, Japan)
Anosmia predicts development of more severe motor symptoms including freezing of gait and impaired balance at 2 year follow-up in PD

N.I. Bohnen, J. Haugen, V. Kotagal, K.A. Frey, R.L. Albin, M.L.T.M. Muller (Ann Arbor, MI, USA)
Anti-GAD antibody cerebellar ataxia mimicking multiple system atrophy

J.B. Parmera, L.S.V. Schneider, R.G. Cury, M.M. Simabukuro, L.H.M. Castro, E.R. Barbosa (São Paulo, Brazil)
Anti-LGI1 encephalitis presenting as a progressive supranuclear palsy-like syndrome

G.A. Da Prat, E.M. Gatto, G.G. Persi, V. Parisi, D. Lisei, L. Rattagan, M. Bres Bullrich, S. Camerlingo, C. Rugilo, M. Titulaer, G. Rojas (Caba, Argentina)
AntiParkinsonian effects of AG-0029 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque model of Parkinson’s disease

E.Y. Pioli, W.K.D. Ko, Q. Li, A. Crossman, E. Bezard, S. Hogg (Manchester, United Kingdom)
AntiParkinsonian effects of the “radiprodil and tozadenant” combination in MPTP-treated marmosets

A. Michel, J.M. Nicolas, S. Rose, M. Jackson, P. Colman, W. Briône, D. Sciberras, P. Muglia, D. Scheller, M. Citron, P. Downey (Braine L'Alleud, Belgium)
AntiParkinsonian medication adjustments following deep brain stimulation of subthalamic nucleus in patients with advanced Parkinson’s disease

A. Gamaleya, E. Bril, A. Tomskiy, A. Poddubskaya, N. Gubareva, N. Fedorova, V. Shabalov (Moscow, Russia)
AntiParkinsonian treatment patterns and motor complications among patients with Parkinson´s disease in Estonia

L. Kadastik-Eerme, N. Taba, P. Taba (Tartu, Estonia)
Anxiety and cognition are associated with dopaminergic dysfunction in de novo Parkinson’s disease

M. Picillo, G. Santangelo, R. Erro, A. Cozzolino, M. Amboni, C. Vitale, P. Barone, M.T. Pellecchia (Baronissi, Italy)
Anxiety and freezing of gait: A new perspective for early intervention

K.A. Ehgoetz Martens, J.M. Hall, M. Gilat, M.J. Georgiades, C.C. Walton, S.J.G. Lewis (Camperdown, Australia)
Anxiety and parkinsonism signs in idiopathic REM sleep behavior disorder

F. Escudier, R.B. Postuma, P.A. Bourgouin, J. Montplaisir, J.F. Gagnon (Montreal, QC, Canada)
Anxiety in patients with Parkinson’s disease

K. Zhu, J.J. van Hilten, J. Marinus (Leiden, Netherlands)
Anxiolytic-like activity of the adenosine A_2A receptor antagonist, istradefylline (KW-6002) in rodent models of anxiety

K. Yamada, M. Kobayashi, J. Kase, A. Mori, P. Jenner, T. Kanda (Shizuoka, Japan)
Apathy and striatal dopamine defects in non-demented patients with Parkinson’s disease

S.J. Chung, J.J. Lee, J.H. Ham, P.H. Lee, Y.H. Sohn (Seoul, Korea)
Apathy phenotype in Parkinson’s disease: Motor and non-motor features

S. Varanese, A. Di Rocco, M.F. Ghilardi, N. Modugno, R. Gilbert-Wolf, B. Perfetti (Pozzilli, Italy)
APL-130277 is a sublingual film being studied in phase 3 trials to rapidly turn patients ON from OFF episodes by delivering apomorphine via the oral mucosa

H. Shill, E.J. Pappert, A. Agro, B. Dzyngel, T. Bilbault, R. Hauser, S. Isaacson (Phoenix, AZ, USA)
Apocyanin ameliorates post-stroke movement disorder in rats: Possible role of neurochemical and inflammatory alterations

M. Kapoor, R. Sandhir, B. Nehru (Chandigarh, India)
Apolipoprotein E genotypes in Brazilian patients with Parkinson’s disease and their correlation with cognitive performance assessed by MoCA

M.M.C.M. Brito, R.S.J. Silva, V. Tumas, I.F. Mata, C.Z. Zabetian (Ribeirão Preto, Brazil)
Apomorphine treatment in advanced Parkinson’s disease (PD): Duration of treatment and safety experience in a managed care program in Germany

D. Maessen, G. Ebersbach, L. Timmermann, A. Ceballos-Baumann (Düsseldorf, Germany)
Appendicitis and risk of Parkinson’s disease: A Danish nationwide population-based cohort study

E. Svensson, E. Horváth-Puhó, M. Stockholm, H. Toft-Sørensen, P. Borghammer (Aarhus N, Denmark)
Applicability study of a multitask cognitive and motor exercise program for individuals with Parkinson´s disease: The COGWEB CNS Move Program

J. Domingos, D. Peralta, R. Loureiro, C. Ribeiro, V.T. Cruz, J. Ferreira (Torres Vedras, Portugal)
Application and correlates of the PSP quality of life scale

L.A. Higginbotham, V. Johnson, A. Pantelyat (Baltimore, MD, USA)
Application of Parkinson’s well-being map to assess impairment of digestive system in patients of Tomsk region, Russia

Y. Mironova, I. Zhukova, N. Zhukova, V. Alifirova, O. Izhboldina, A. Latypova, M. Nikitina (Tomsk, Russia)
Application of the MDS research criteria for prodromal Parkinson’s disease to the longitudinal population-based Bruneck study cohort

P. Mahlknecht, A. Gasperi, P. Willeit, S. Kiechl, H. Stockner, J. Willeit, G. Rungger, W. Poewe, K. Seppi (Innsbruck, Austria)
Apraclonidine in blepharospasm

J. Jankovic, D. Vijayakumar, S. Wijemanne (Houston, TX, USA)
Apraclonidine in the treatment of ptosis

S. Wijemanne, D. Vijayakumar, J. Jankovic (Houston, TX, USA)
Apraxia in Parkinson’s disease

M. Tábuas-Pereira, P. Correia, F. Moreira, A. Morgadinho, C. Januário (Coimbra, Portugal)
Apraxia of speech as the initial manifestation of progressive supranuclear palsy

J.J. Bravo, M.J. Gallardo, J.P. Cabello, R.E. Ibañez, J. Vaamonde (Ciudad Real, Spain)
Aquatic physical therapy: Functional motor skills in people with Parkinson’s disease

V.L. Israel, B. Yamaguchi, V.L. Israel (Curitiba, Brazil)
Are clinical certainty ratings helpful in the diagnosis of Parkinson’s disease?

H.V. Gupta, S.H. Mehta, J.G. Hentz, H.A. Shill, E. Driver-Dunckley, M.N. Sabbagh, C.M. Belden, B.N. Dugger, T.G. Beach, G.E. Serrano, L.I. Sue, C.H. Adler (Scottsdale, AZ, USA)
Are inflammatory bowel disease and/or treatment with aminosalicylates protective factors against Parkinson’s disease?

F. Escamilla-Sevilla, J. Pinel-Ríos, C.J. Madrid-Navarro, R. Piñar-Morales, J.D. Herrera-García, M.J. Pérez-Navarro, C. Del Canto-Pérez, M.J. Cabello-Tapia, M.d.m. Martín-Rodríguez, D. Sánchez-Capilla, M.J. Piña-Vera, A. Aguilar-Muñoz, V. Campos-Arillo, J. Gutiérrez-García, C.E. Chamorro-Santos, M.R. Gómez-García, A. Mínguez-Castellanos (Granada, Spain)
Are limbic and cognitive effects on balance in Parkinson’s disease equal?

K.A. Ehgoetz Martens, C.G. Ellard, Q.J. Almeida (Camperdown, Australia)
Are Parkinson’s disease futility studies futile?

B.C. Tilley, J. Elm (Houston, TX, USA)
Are people with Parkinson’s disease living in care homes in the UK underserved? Identifying models of care and barriers to care access

L.L. Oates, A. Hand, R.W. Walker, W.K. Gray, P. Reynolds, L. Cockram (North Shields, United Kingdom)
Are we speaking the same language? A pilot study to evaluate the agreement in clinical phenotyping of children with cerebral palsy

H. Eggink, D. Kremer, O.F. Brouwer, M.F. Contarino, M.E. van Egmond, A. Elema, K. Folmer, J.F. van Hoorn, L.A. van de Pol, V. Roelfsema, M.A.J. Tijssen (Groningen, Netherlands)
Arterial spin labeling perfusion MRI compensate for other diagnostic tools in evaluation of Parkinson’s disease with dementia

K. Abe, T. Hayashi, N. Akiyama, M. Yamamoto, M. Fujita (Nishinomiya, Japan)
Articulography reveals disturbed speech motor control in ET patients treated with VIM-DBS

M.T. Barbe, D. Mücke, A. Hermes, T.B. Roettger, J. Becker, M. Opitz, T.A. Dembek, M. Hartinger, I.G. Meister, V. Visser-Vandewalle, M. Grice, L. Timmermann (Cologne, Germany)
Assessing the impact of PD motor symptom states on quality of life in patients with advanced Parkinson’s disease

Y. Jalundhwala, P. Kandukuri, T. Marshall, A. Yucel, K. Chatamra, K. Sail (Mettawa, IL, USA)
Assessing vestibular function in individuals with cervical dystonia and the effects of botulinum toxin treatment

K.L. Andrzejewski, A. Owens, M.T. Bull, K.M. Biglan, S. Kanchana, J.W. Mink, R. Barbano (Rochester, NY, USA)
Assessment and connection to care: The vital role of the social worker in an interdisciplinary home visit program for advanced Parkinson’s disease patients

M.M. Sweeney, A.C. Lemen, S.E. Oyler, R.M. Gilbert, A. Fazl, J. Chodosh, A. Di Rocco, J.E. Fleisher (New York, NY, USA)
Assessment of brainstem function with blink reflex variations in Parkinson’s disease

D. Weise, C. Pargac, J.J. Rumpf, C. Fricke, J. Classen (Leipzig, Germany)
Assessment of cognitive-motor interference during an upper extremity motor task in Parkinson’s disease

P.J.M. Bank, J. Marinus, J.H. de Groot, J.J. van Hilten, C.G.M. Meskers (Leiden, Netherlands)
Assessment of freezing of gait in Parkinson’s disease patients treated with STN-DBS

K. Peterova, E. Ruzicka, R. Jech, J. Rusz, E. Plananská, L. Brabcová, H. Brozová (Prague, Czech Republic)
Assessment of gait dysfunction in patients with Parkinson’s disease and REM behavioral disorder

L.R. Niemand, A. Dang, C. Singer, C.C. Luca (Miami, FL, USA)
Assessment of humor in Parkinson’s disease and the effect of deep brain stimulation

A. Greuel, C.J. Lewis, F. Maier, R. Dano, S. Heintz, W. Ruch, C. Eggers (Cologne, Germany)
Assessment of malnutrition in patients with Parkinson’s disease

O. Yilmaz Kusbeci, I. Inci, B. Donmez Colakoglu, N. Erdogmus Ince, R. Cakmur (Izmir, Turkey)
Assessment of need for treatment with botulinum toxin type A in cervical dystonia patients

C.L. Vaughan, G.T. Stebbins, C.L. Comella (Charleston, SC, USA)
Assessment of olfactory dysfunction in Parkinson’s disease with an objective test

Y. Sucullu Karadag, N. Turkmen, O. Gulten, A. Eryilmaz, A. Altundag, N. Subutay Oztekin, F. Ak (Ankara, Turkey)
Assessment of oral hygiene status before and after the use of powered tooth brush in patients with Parkinson’s diseases

F. Pullishery, F.M. Kuyyadi (Malappuram, India)
Assessment of Parkinson’s disease risk loci as DNA methylation quantitative trait loci

D.G. Hernandez, C. Letson, J. Simon-Sanchez, T.R. Price, M.A. Nalls, A.B. Singleton (Bethesda, MD, USA)
Assessment of subclinical cerebellar involvement in progressive supranuclear palsy using SUIT based volumetric analysis

A. Lenka, L. George, K.R. Jhunjhunwala, S.A. Pasha, S. Mangalore, J. Saini, R. Yadav, P.K. Pal (Bangalore, India)
Assessment of the quality of life of patients with Parkinson’s disease

S. Lukmonov, D. Tolibov, A. Sobirov, F. Yunusov, K. Abdukhalimova, D. Jamilov, R. Agzamov, S. Tursunov (Tashkent, Uzbekistan)
Associated and predictive factors of depressive symptoms in patients with Parkinson’s disease

K. Zhu, J.J. Van Hilten, J. Marinus (Leiden, Netherlands)
Association analysis of NALCN polymorphisms rs1338041 and rs61973742 in a Chinese population with isolated cervical dystonia

Q. Zhou, J. Yang, B. Cao, Y. Chen, Q. Wei, R. Ou, W. Song, B. Zhao, Y. Wu, H. Shang (Chengdu, People's Republic of China)
Association analysis of SNP rs11868035 in SREBF1 with Parkinson’s disease, amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population

X. Yuan, Y. Chen, B. Cao, Q. Wei, R. Ou, H. Shang (Chengdu, People's Republic of China)
Association between clinical features and pre- and post-synaptic dopaminergic dysfunction in multiple system atrophy: [18F]-FP-CIT PET and [18F]-FDG PET analyses

H.S. Ryu, M. Oh, M.J. Kim, S. You, Y.J. Kim, J. Kim, K. Kim, H. Moon, J. Oh, J.S. Kim, S.J. Chung (Seoul, Korea)
Association between cognitive status and mobility performance in dual task condition in patients with Parkinson’s disease

S.M.A.A. Pompeu, T.B. Freitas, K.G. Silva, C. Torriani-Pasin, F. Doná, J.E. Pompeu (São Paulo, Brazil)
Association between urine protein/creatinine ratio and cognitive dysfunction in Parkinson’s disease

Y.S. Oh, J.S. Kim, K.S. Lee (Seoul, Korea)
Association of amyotrophic lateral sclerosis with basal ganglia impairment

D. Mirzaeva, A. Prokhorova, B. Muinjanov, P. Deleyn (Tashkent, Uzbekistan)
Association of four new candidate genetic variants with Parkinson’s disease in Han Chinese

L. Wang, L. Cheng, N.N. Li, W.J. Yu, X.Y. Sun, R. Peng (Chengdu, People's Republic of China)
Association of mood and affective disorders with pain in Parkinson’s disease

J.S. Kim, W. Jang, J. Park, E. Oh, J. Youn, J.W. Cho (Seoul, Korea)
Association of Parkinson’s disease severity and cortical and subcortical cognitive markers

H. Duran-Meza, A.D. Santana-Vargas, J.D. Ramirez-Diossa, G.H. Terrazas Gonzalez, G. Millan-Rosas, U. Jimenez-Correa, M. Lopez-Ruiz (Mexico City, Mexico)
Association of Parkinson’s disease with essential tremor

D. Aygun (Samsun, Turkey)
Association of the DRD2 (CA) n and DRD3 Ser9Gly polymorphisms with Parkinson’s disease and response of dopamine agonists

S. Xu, J. Liu, X. Yang, Y. Qian, Q. Xiao (Shanghai, People's Republic of China)
Association of UV radiation with Parkinson’s disease incidence: A nationwide French ecologic study

A. Elbaz, K. Sofiane, L. Wald, A. Dugravot, A. Singh-Manoux, F. Moisan, A. Kravietz (Villejuif, France)
Association or causation? Orthostatic hypotension and cognitive impairment in α-synucleinopathies: A systematic review

S.J. Udow, A.E. Lang, M. Masellis (Toronto, ON, Canada)
Associations between cerebrospinal fluid proteins and cytokines in Parkinson’s disease

R. Wijeyekoon, S. Moore, K. Farrell, D. Breen, R. Barker, C.H. Williams-Gray (Cambridge, United Kingdom)
Astroglia exert a neuro-protective role in Parkinson’s disease by reducing oxygen stress through dopamine-induced activation of the pentose-phosphate pathway

K. Mashima, S. Takahashi, T. Iizumi, T. Abe, N. Suzuki (Tokyo, Japan)
Ataxic gait in subjects with essential tremor and thalamic neurostimulation is caused by posteromedial current spread in the (sub)thalamic area

M.M. Reich, J. Brumberg, N. Pozzi, M. Åström, R. Nijlunsing, T. Musacchio, F. Steigerwald, G. Marotta, A. Buck, J. Volkmann, I.U. Isaias (Wuerzburg, Germany)
Attention and dopamine: Increased distractibility in Parkinson’s disease

C. Warden, S. YorkWilliams, N. Ahn, D. Everling, K.L. Poston (Stanford, CA, USA)
Attention to action: Common to both conversion (psychogenic) and Parkinsonian (neurogenic) motor speech disorders

S. Sapir (Haifa, Israel)
Atypical Parkinsonian disorders: Insights for a differential diagnosis through the analysis of oculomotor profile in MSA, PSP and CBD patients

F. Rosini, G. Lucii, P. Federighi, E. Pretegiani, F. Giannini, R. Rocchi, A. Federico, A. Rufa (Siena, Italy)
Atypical parkinsonism in C9orf72 expansions: A case report and systematic review of 45 cases from the literature

C. Wilke, J.K. Pomper, S. Biskup, C. Puskás, D. Berg, M. Synofzik (Tübingen, Germany)
Atypical presentation of psychogenic movement disorder with jaw-opening dystonia: Two cases reports

W.T. Yoon (Seoul, Korea)
Auditory cues during obstacle crossing increase gait asymmetry in neurologically health individuals but not in people with Parkinson’s disease

M.B. Pestana, L.T.B. Gobbi, L. Simieli, D. Orcioli-Silva, A.M. Baptista, V.S. Beretta, P.C.R. Santos, T. Penedo, V.I.A. Pereira, F.A. Barbieri (Rio Claro, Brazil)
Auditory function and speech discrimination abilities are impaired in progressive supranuclear palsy

C. Vitale, G. Santangelo, R. Allocca, T. Abbate, S. Peluso, G. De Michele, M. Moccia, M. Picillo, D. Tafuri, P. Barone, M. Cavaliere (Naples, Italy)
Augmentation and impulse control disorders in restless legs syndrome – Coexistence or association?

B. Heim, L. Zamarian, A. Heidbreder, A. Stefani, M.T. Pertl, E. Brandauer, K. Seppi, M. Delazer, W. Poewe, B. Högl, A. Djamshidian (Innsbruck, Austria)
Automated assessment of advanced motor Parkinson’s disease; a pilot study of the Parkinson’s KinetiGraph as an objective tool for measurement of motor fluctuations

P. Bogdanova-Mihaylova, N. Kavanagh, R.A. Walsh (Dublin, Ireland)
Automated Telehealth Diagnostics for Remote Parkinson Monitoring

D.A. Heldman, D.A. Harris, T. Felong, B. Goldberg, J.P. Giuffrida, E.R. Dorsey, M.A. Burack (Cleveland, OH, USA)
Automatic event-detection for the neurophysiological evaluation of voluntary and involuntary movements

D. Benninger, J. Rechenmann, N. Chao, J. del R. Millan, R. Chavarriaga (Lausanne, Switzerland)
Autonomic failure and circadian rhythm of arterial blood pressure in IDIOPATHIC REM behaviour disorders and Parkinson’s disease

R. Zangaglia, E. Guaschino, N. Ghiotto, B. Minafra, M. Terzaghi, G. Capone, A. Spiritelli, D. Bosone, C. Pacchetti (Pavia, Italy)
Autophagic modulation by rosuvastatin prevent rotenone induced neurotoxicity as an in vitro model of Parkinson’s disease

W. Jang (Gangneung, Korea)
Autosomal recessive ataxia due to ANO10 mutations; full and novel phenotypic data in an Irish pedigree

P. Bogdanova-Mihaylova, N. Austin, M.D. Alexander, L. Cassidy, S.M. Murphy, R.A. Walsh (Dublin, Ireland)
Awareness and perception of gastrointestinal symptoms in Parkinson´s disease: A survey of patients and caregiving relatives

P. Themann (Halsbrücke, Germany)
Axial prominent, delayed onset dystonia in cerebral palsy: Highlights on a distinct phenotype with favorable outcome following deep brain stimulation

L. Cif, V. Gonzalez Martinez, E. Sanrey, E. Nerrant, M. Ros, F. Cyprien, E. Chan Seng, T. Roujeau, P. Coubes (Montpellier, France)